Ftse Mib
34.144,92
-0,67%
DAX
18.503,22
-0,52%
S&P 500
5.631,22
0,28%
NASDAQ
18.472,57
0,40%
Bitcoin
62.874,32
-3,05%
Registration Strip Icon for discussion Registrati per interagire nei nostri forum attivi per discutere con investitori con idee simili.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. USOTC Hepion Pharmaceuticals Inc (PK) (CTRVP) Hepion Pharmaceuticals Inc (PK) (CTRVP) Notizie

CTRVP

Hepion Pharmaceuticals (PK) (CTRVP)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:USOTC:CTRVP
DataOraFonteTitoloSimboloCompagnia
15/07/202423:17Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]USOTC:CTRVPHepion Pharmaceuticals Inc (PK)
11/07/202415:46Edgar (US Regulatory)Form S-1 - General form for registration of securities under the Securities Act of 1933USOTC:CTRVPHepion Pharmaceuticals Inc (PK)
07/03/202422:15Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesUSOTC:CTRVPHepion Pharmaceuticals Inc (PK)
06/03/202422:30Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesUSOTC:CTRVPHepion Pharmaceuticals Inc (PK)
20/02/202422:15Edgar (US Regulatory)Form 8-K - Current reportUSOTC:CTRVPHepion Pharmaceuticals Inc (PK)
20/11/202321:59Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]USOTC:CTRVPHepion Pharmaceuticals Inc (PK)
03/10/202323:22Edgar (US Regulatory)Form D - Notice of Exempt Offering of SecuritiesUSOTC:CTRVPHepion Pharmaceuticals Inc (PK)
02/10/202322:52Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]USOTC:CTRVPHepion Pharmaceuticals Inc (PK)
14/07/202323:12Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansUSOTC:CTRVPHepion Pharmaceuticals Inc (PK)
12/05/202322:19Edgar (US Regulatory)Quarterly Report (10-q)USOTC:CTRVPHepion Pharmaceuticals Inc (PK)
10/04/202322:52Edgar (US Regulatory)Annual Report (10-k)USOTC:CTRVPHepion Pharmaceuticals Inc (PK)
03/04/202312:02Edgar (US Regulatory)Notification That Annual Report Will Be Submitted Late (nt 10-k)USOTC:CTRVPHepion Pharmaceuticals Inc (PK)
21/11/202223:08Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)USOTC:CTRVPHepion Pharmaceuticals Inc (PK)
09/11/202223:21Edgar (US Regulatory)Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)USOTC:CTRVPHepion Pharmaceuticals Inc (PK)
09/11/202212:07Edgar (US Regulatory)Current Report Filing (8-k)USOTC:CTRVPHepion Pharmaceuticals Inc (PK)
26/07/202222:06Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)USOTC:CTRVPHepion Pharmaceuticals Inc (PK)
05/07/202214:34Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)USOTC:CTRVPHepion Pharmaceuticals Inc (PK)
14/02/202212:16Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)USOTC:CTRVPHepion Pharmaceuticals Inc (PK)
26/11/202112:09Edgar (US Regulatory)Notice of Effectiveness (effect)USOTC:CTRVPHepion Pharmaceuticals Inc (PK)
19/11/202123:01Edgar (US Regulatory)Securities Registration Statement (simplified Form) (s-3/a)USOTC:CTRVPHepion Pharmaceuticals Inc (PK)
21/05/202101:13Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)USOTC:CTRVPHepion Pharmaceuticals Inc (PK)
28/04/202123:14Edgar (US Regulatory)Amended Annual Report (10-k/a)USOTC:CTRVPHepion Pharmaceuticals Inc (PK)
24/02/202116:48Edgar (US Regulatory)Statement of Ownership (sc 13g)USOTC:CTRVPHepion Pharmaceuticals Inc (PK)
16/02/202123:20Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)USOTC:CTRVPHepion Pharmaceuticals Inc (PK)
13/02/202100:33Edgar (US Regulatory)Free Writing Prospectus - Filing Under Securities Act Rules 163/433 (fwp)USOTC:CTRVPHepion Pharmaceuticals Inc (PK)
25/11/202022:29Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(4) (424b4)USOTC:CTRVPHepion Pharmaceuticals Inc (PK)
18/11/202023:29Edgar (US Regulatory)Securities Registration Statement (s-1/a)USOTC:CTRVPHepion Pharmaceuticals Inc (PK)
29/10/202021:07Edgar (US Regulatory)Securities Registration Statement (s-1)USOTC:CTRVPHepion Pharmaceuticals Inc (PK)
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:USOTC:CTRVP

La tua Cronologia

BIT
FBK
Finecobank
BIT
UCG
Unicredit
BIT
STLAM
Stellantis NV
BIT
RACE
Ferrari NV
BIT
ISP
Intesa Sanpaolo
BIT
ENEL
Enel
BIT
ENI
Eni
BIT
MONC
Moncler
BIT
BC
Brunello Cucinelli
BIT
LDO
Leonardo
BIT
SPM
Saipem
BIT
BMPS
Banca Monte Dei Paschi D...
BIT
STMMI
ST Microelectronics
BIT
G
Generali
BIT
AMP
Amplifon
BIT
BPE
Bper Banca
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network